NASDAQ: GNLNGreenlane Holdings Inc Stock
$0.55-0.05 (-8.33%)
Updated Apr 24, 2024
GNLN Price
$0.55
Fair Value Price
N/A
Market Cap
$2.06M
52 Week Low
$0.37
52 Week High
$3.65
P/E
-0.01x
P/B
0.13x
P/S
0.05x
PEG
N/A
Dividend Yield
N/A
Revenue
$77.34M
Earnings
-$94.79M
Gross Margin
24.8%
Operating Margin
-114.91%
Profit Margin
-122.6%
Debt to Equity
2.14
Operating Cash Flow
-$3M
Beta
1.23
Next Earnings
May 13, 2024
Ex-Dividend
N/A
Next Dividend
N/A
GNLN Overview
Greenlane Holdings, Inc. develops and distributes cannabis accessories, child-resistant packaging, vape solutions, and lifestyle products in the United States, Canada, and Europe. It operates through two segments, Consumer Goods and Industrial Goods. The company provides consumption accessories, vaporizers, pipes, rolling papers and packaging, grinders, and apparel lines, as well as bubblers, rigs, and other smoking and vaporization related accessories and merchandise. It offers its products under the VIBES rolling papers, Pollen Gear, the Marley Natural accessory line, Aerospaced & Groove grinders, Marley Natural, K. Haring Glass Collections, Eyce silicone pipes, Higher Standards, and DaVinci vaporizers brands. The company also operates e-commerce websites, such as Vapor.com, Higherstandards.com, Aerospaced.com, DaVincivaporizer.com, Harringglass.com, Eycemolds.com, Vapor.ca, Vaposhop.com, and Puffitup.com. It serves customers through a network of 8,500 smoke shops, cannabis dispensaries, and specialty retailers. Greenlane Holdings, Inc. was founded in 2005 and is headquartered in Boca Raton, Florida.
Zen Score
–
Industry Average (30)
You've viewed Zen Score for 10/10 free stocks. Upgrade to Premium to see how GNLN scored across 33 valuation, financial, forecast, performance, and dividend due diligence checks.
Due Diligence Checks
GNLN is unprofitable, so we are unable to calculate its intrinsic value according to an updated version of Benjamin Graham's Formula from "The Intelligent Investor"
Below Benjamin Graham Formula Value Valuation
GNLN is good value based on its book value relative to its share price (0.13x), compared to the US Tobacco industry average (5.86x)
P/B vs Industry Valuation
GNLN is unprofitable, so we... subscribe to Premium to read more.
PEG Value Valuation
There are 30 more GNLN due diligence checks available for Premium users.
Be the first to know about important GNLN news, forecast changes, insider trades & much more!
GNLN News
Valuation
GNLN fair value
Fair Value of GNLN stock based on Discounted Cash Flow (DCF)
Price
$0.55
Fair Value
$367.77
Undervalued by
99.85%
GNLN is unprofitable, so we... subscribe to Premium to read more.
Below Benjamin Graham Formula Value Valuation
GNLN price to earnings (PE)
For valuing profitable companies with steady earnings
Company
-0.01x
Industry
11.69x
Market
41.27x
GNLN price to book (PB)
For valuing companies that are loss-making or have lots of physical asset
Company
0.13x
Industry
5.86x
GNLN is good value based... subscribe to Premium to read more.
P/B vs Industry Valuation
GNLN's financial health
Profit margin
Revenue
$11.8M
Net Income
-$10.1M
Profit Margin
-85.7%
GNLN's cash burn is expected... subscribe to Premium to read more.
Interest Coverage Financials
GNLN's profit margin has decreased... subscribe to Premium to read more.
Profit Margin Growth Financials
Assets to liabilities
Assets
$48.4M
Liabilities
$33.0M
Debt to equity
2.14
GNLN's short-term assets ($37.51M) exceed... subscribe to Premium to read more.
Short-term Liabilities Financials
GNLN's short-term assets ($37.51M) exceed... subscribe to Premium to read more.
Long-term Liabilities Financials
GNLN's debt to equity ratio... subscribe to Premium to read more.
Healthy Debt to Equity Financials
Cash flow
Operating
-$3.5M
Investing
-$327.0k
Financing
$1.6M
GNLN's cash and short-term investments... subscribe to Premium to read more.
Debt Coverage Financials
GNLN vs Tobacco Stocks
Greenlane Holdings Stock FAQ
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.